Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification.
Ferro M, Rocco B, Maggi M, Lucarelli G, Falagario UG, Del Giudice F, Crocetto F, Barone B, La Civita E, Lasorsa F, Brescia A, Catellani M, Busetto GM, Tataru OS, Terracciano D. Ferro M, et al. Among authors: catellani m. Expert Rev Mol Diagn. 2023 Jul-Dec;23(12):1061-1070. doi: 10.1080/14737159.2023.2277366. Epub 2023 Dec 15. Expert Rev Mol Diagn. 2023. PMID: 37897252 Review.
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.
Luzzago S, Musi G, Catellani M, Russo A, Di Trapani E, Mistretta FA, Bianchi R, Cozzi G, Conti A, Pricolo P, Ferro M, Matei DV, Mirone V, Petralia G, de Cobelli O. Luzzago S, et al. Among authors: catellani m. Urol Int. 2018;101(1):56-64. doi: 10.1159/000488772. Epub 2018 May 7. Urol Int. 2018. PMID: 29734177
Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients.
Ferro M, Musi G, Serino A, Cozzi G, Mistretta FA, Costa B, Bianchi R, Cordima G, Luzzago S, Di Trapani E, Tagliabue E, Vartolomei MD, Terracciano D, Cassatella MC, Salvatici M, Conti A, Sandri MT, Cioffi A, Turetti M, Catellani M, Bottero D, Matei DV, Mirone V, de Cobelli O. Ferro M, et al. Among authors: catellani m. Urol Int. 2019;102(1):43-50. doi: 10.1159/000494259. Epub 2018 Nov 8. Urol Int. 2019. PMID: 30408799
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up.
Luzzago S, Catellani M, Di Trapani E, Cozzi G, Mistretta FA, Bianchi R, Pricolo P, Conti A, Ancona E, Piacentini N, Alessi S, Renne G, Ferro M, Matei DV, Musi G, Jereczek-Fossa BA, Petralia G, de Cobelli O. Luzzago S, et al. Among authors: catellani m. Prostate Cancer Prostatic Dis. 2020 Mar;23(1):94-101. doi: 10.1038/s41391-019-0160-3. Epub 2019 Jun 27. Prostate Cancer Prostatic Dis. 2020. PMID: 31249386
A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
Luzzago S, de Cobelli O, Cozzi G, Peveri G, Bagnardi V, Catellani M, Di Trapani E, Mistretta FA, Pricolo P, Conti A, Alessi S, Marvaso G, Ferro M, Matei DV, Renne G, Jereczek-Fossa BA, Petralia G, Musi G. Luzzago S, et al. Among authors: catellani m. BJU Int. 2020 Jul;126(1):104-113. doi: 10.1111/bju.15048. Epub 2020 Apr 1. BJU Int. 2020. PMID: 32150328 Free article.
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center.
Di Trapani E, Musi G, Ferro M, Cordima G, Mistretta FA, Luzzago S, Bianchi R, Cozzi G, Alessi S, Catellani M, Matei DV, Jereczek-Fossa BA, Petralia G, De Cobelli O. Di Trapani E, et al. Among authors: catellani m. Scand J Urol. 2020 Oct;54(5):382-386. doi: 10.1080/21681805.2020.1798503. Epub 2020 Aug 10. Scand J Urol. 2020. PMID: 32772805
Robot-Assisted Radical Cystectomy for Nonmetastatic Urothelial Carcinoma of Urinary Bladder: A Comparison Between Intracorporeal Versus Extracorporeal Orthotopic Ileal Neobladder.
Mistretta FA, Musi G, Collà Ruvolo C, Conti A, Luzzago S, Catellani M, Di Trapani E, Cozzi G, Bianchi R, Ferro M, Cioffi A, Cordima G, Brescia A, Verweij F, Bottero D, Matei DV, Mirone V, De Cobelli O. Mistretta FA, et al. Among authors: catellani m. J Endourol. 2021 Feb;35(2):151-158. doi: 10.1089/end.2020.0622. Epub 2020 Oct 30. J Endourol. 2021. PMID: 32977727
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort.
Luzzago S, de Cobelli O, Mistretta FA, Piccinelli ML, Lorusso V, Morelli M, Bianchi R, Catellani M, Cozzi G, Di Trapani E, Pricolo P, Alessi S, Ferro M, Marvaso G, Matei DV, Jereczek-Fossa BA, Petralia G, Musi G. Luzzago S, et al. Among authors: catellani m. Prostate Cancer Prostatic Dis. 2021 Jun;24(2):406-413. doi: 10.1038/s41391-020-00290-4. Epub 2020 Sep 28. Prostate Cancer Prostatic Dis. 2021. PMID: 32989259
82 results